Related Experiment Video

Updated: Apr 21, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K

[Involvement of miR-200a in chemosensitivity regulation of ovarian cancer]

Na Liu1, Jie Zeng1, Xiaomei Zhang1

  • 1Department of Obstetrics & Gynecology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.

Zhonghua Yi Xue Za Zhi
|October 21, 2014
PubMed
Abstract

Insights

MicroRNA-200a (miR-200a) enhances ovarian cancer cell sensitivity to paclitaxel by down-regulating chemoresistance genes. However, its direct interaction with ABCG2 mRNA 3'untranslated region was not confirmed.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Ovarian cancer remains a leading cause of cancer-related deaths in women.
  • Chemotherapy resistance is a major challenge in ovarian cancer treatment.
  • MicroRNAs (miRNAs) are emerging as key regulators of cancer progression and drug response.

Purpose of the Study:

  • To investigate the role of miR-200a in regulating chemosensitivity in ovarian cancer.
  • To determine if miR-200a affects the expression of ATP-binding cassette (ABC) transporter genes involved in chemoresistance.
  • To elucidate the mechanism by which miR-200a influences drug response in ovarian cancer cells.

Main Methods:

  • miR-200a was overexpressed in ovarian cancer cell lines (SKOV-3, ES-2) using lentiviral vectors.
  • Cytotoxicity of paclitaxel and cisplatin was assessed using the MTT assay.
  • Expression levels of chemoresistance-associated ABC genes were analyzed by quantitative real-time PCR and Western blot.
  • The interaction between miR-200a and ABCG2 mRNA 3'-UTR was examined using a dual-luciferase reporter assay.

Main Results:

  • Successful overexpression of miR-200a was achieved in SKOV-3 and ES-2 cells.
  • miR-200a significantly enhanced sensitivity to paclitaxel but not cisplatin.
  • Down-regulation of several ABC family genes (ABCB3, ABCC1, ABCC2, ABCC3, ABCG2) was observed following miR-200a overexpression.
  • No direct interaction between miR-200a and the 3'-UTR of ABCG2 mRNA was detected.

Conclusions:

  • Overexpression of miR-200a may improve paclitaxel chemosensitivity in ovarian cancer by negatively regulating ABC family genes.
  • The mechanism of miR-200a-mediated chemoresistance regulation does not appear to involve direct interaction with the ABCG2 mRNA 3'-UTR.
  • Further research is needed to fully understand the complex role of miR-200a in ovarian cancer chemoresistance.

More Related Videos

A Proximal Culture Method to Study Paracrine Signaling Between Cells08:17

A Proximal Culture Method to Study Paracrine Signaling Between Cells

Published on: August 28, 2018

9.3K
Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time14:25

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Published on: May 20, 2014

20.2K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K